These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15450343)

  • 1. Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist.
    Ruderman EM; Tambar S
    Dermatol Clin; 2004 Oct; 22(4):477-86, x. PubMed ID: 15450343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the recurrence risk of arthritis among psoriatic patients.
    Pedersen OB; Junker P
    Scand J Rheumatol; 2009; 38(4):321-2. PubMed ID: 19308804
    [No Abstract]   [Full Text] [Related]  

  • 3. Psoriatic arthritis update.
    Mease P
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):25-31. PubMed ID: 17121486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psoriatic arthritis: what the dermatologist needs to know, Part 2].
    López-Ferrer A; Torrente-Segarra V; Puig L
    Actas Dermosifiliogr; 2010 Nov; 101(9):742-8. PubMed ID: 21034704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthopedic manifestations and management of psoriatic arthritis.
    Strauss EJ; Alfonso D; Baidwan G; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2008 Mar; 37(3):138-47. PubMed ID: 18438469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
    Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
    Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriatic arthritis.
    Holdsworth J
    Nurs Stand; 2003 Oct 15-21; 18(5):47-52; quiz 54-5. PubMed ID: 14603767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriatic arthritis screening tools.
    Qureshi AA; Dominguez P; Duffin KC; Gladman DD; Helliwell P; Mease PJ; Husni ME
    J Rheumatol; 2008 Jul; 35(7):1423-5. PubMed ID: 18609737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a preliminary composite disease activity index in psoriatic arthritis.
    Mumtaz A; Gallagher P; Kirby B; Waxman R; Coates LC; Veale J D; Helliwell P; FitzGerald O
    Ann Rheum Dis; 2011 Feb; 70(2):272-7. PubMed ID: 21115550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept for psoriasis in the pediatric population: experience in nine patients.
    Hawrot AC; Metry DW; Theos AJ; Levy ML
    Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis and arthroplasty: a review of the literature.
    lofin I; Levine B; Badlani N; Klein GR; Jaffe WL
    Bull NYU Hosp Jt Dis; 2008; 66(1):41-8. PubMed ID: 18333827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
    Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D
    Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of psoriatic arthritis in a population of patients with psoriasis].
    Jajić Z; el Assadi G
    Acta Med Croatica; 2003; 57(4):323-6. PubMed ID: 14639870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
    Radtke MA; Reich K; Blome C; Rustenbach S; Augustin M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):683-91. PubMed ID: 19309433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.